Dr. Ivo Lukitsch, MD

Dr. Lukitsch practices at St. Charles Parish Hospital in Luling, Louisiana, part of Ochsner Health System.

Dr. Lukitsch's NPI, 1962675967, was assigned on April 10, 2008. Dr. Lukitsch holds Louisiana license 201945.

Dr. Lukitsch's primary practice is St. Charles Parish Hospital, at 1057 Paul Maillard Road, Luling, LA 70070 in St. Charles Parish. The practice phone is (985) 785-3644.

Dr. Lukitsch's primary practice is St. Charles Parish Hospital in Luling, Louisiana, part of Ochsner Health System. Dr. Lukitsch is also affiliated with Ochsner Medical Center - New Orleans. The medical group on file is Ochsner Health. Dmand AI also links Dr. Lukitsch to 3 more hospitals and 2 dialysis centers, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Lukitsch practices, 7 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Lukitsch's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Lukitsch is licensed in Louisiana.

CMS data shows 343 Medicare services from Dr. Lukitsch across 7 procedure codes in 2024, for 153 Medicare patients. Medicare paid $23,126 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 153 Medicare patients who saw Dr. Lukitsch in 2024. The largest group is 65 to 74, with 63 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 24% are also on Medicaid. Their average risk score is 4.53, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Lukitsch's median patient age at 72, with 47% women.

In 2024, Dr. Lukitsch wrote 1,305 Medicare Part D claims for 181 patients. 85% of them were for generic drugs. CMS names the drug for 1,088 of them, across 32 drugs with 11 or more claims each, at $243,152 in total drug cost. In 2023, CMS named 1,071 claims across 30 drugs.

Dr. Lukitsch accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Lukitsch as offering telehealth.

Dmand AI links 12 papers to Dr. Lukitsch, published from 2010 to 2025. 2020 was the busiest year, with 3. The most frequent topics are Acute Kidney Injury, Autoantibodies and COVID-19. Dr. Lukitsch has published most often in Kidney360. Dr. Lukitsch's most frequent co-authors are Akanksh Ramanand, Arnold B. Alper, MD and Damodar Reddy Kumbala, MD.

CMS Open Payments shows 51 general payments to Dr. Lukitsch from 18 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 78% of the total. Novartis Pharmaceuticals Corporation paid the most, $1,936.